Methylation Optimizer
Methylation Optimizer, licence 80087972: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Methyl Support, Youtrients Methyl Optimizer, Youtrients Methyl Support, Youtrients Methylation Optimizer, Youtrients Methylation Support
- Licence holder
- The DNA Company Inc.
- NPN or DIN-HM
- 80087972
- Status
- Inactive licence
- Licence date
- 23 August 2018
- Revision date
- 28 February 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 180 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 180 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 50.0 mg | 100,000 µg |
| Thiamine Source : Thiamine | 50.0 mg | 100,000 µg |
| Niacine Source : Niacine | 50.0 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 90.0 mg | 180,000 µg |
| Inositol Source : Monophosphate d'inositol | 50.0 mg | Not calculated |
| Choline Source : Bitartrate de choline | 50.0 mg | Not calculated |
| Biotine Source : Biotine | 200.0 mcg | 400 µg |
| 1-Carboxy-N,N,N-sel interne de triméthylméthanaminium Source : Chlorhydrate de bétaine | 200.0 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 500.0 UI | 25 µg |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps the body to metabolize carbohydrates, fats and proteins. Helps normal growth. Helps in energy metabolism and in tissue formation. Helps to maintain healthy mucous membranes. Helps to maintain normal red blood cells. Helps to maintain normal metabolism of iron. Helps to support liver function. Helps to maintain cognitive functions. Helps to support normal early fetal development. Helps to support normal early development of the fetal brain and spinal cord. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps to build strong bones and teeth. Helps in the process of normal cell division. Helps to maintain immune function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80087972
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.